Indonesian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
antifungal/kanker payudara
Tautan disimpan ke clipboard
Halaman 1 dari 301 hasil
Methods for identifying treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION
1. Field of the Invention
The field of this invention is identifying, treating and monitoring patients having breast cancer or patients at risk of getting breast cancer.
2. Description of the Background Art
Estrogen activity has an established relationship to breast
Method for NGF assay for in vitro diagnosis of breast cancer and therapeutic use
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
The present invention relates to the field of cancerology. More particularly, the present invention relates to a method for the diagnosis of breast cancer in a human patient by determining the presence of nerve growth factor (NGF) in a biological sample derived from this patient, it being possible
Detecting agent and therapeutic agent for highly malignant breast cancer
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
TECHNICAL FIELD
The present invention relates to detection agents and therapeutic agents for high malignancy breast cancer. More specifically, it relates to reagents for detecting proteins specific to high malignancy breast cancer, and to therapeutic agents for high malignancy breast cancer by using
Breast cancer therapeutic agent containing 5'-hydroxy-5-nitro-indirubin-3'-oxime as active ingredient
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
This U.S. application claims priority to Korean Patent Application No. 10-2016-157929 filed on Nov. 25, 2016, the contents of which are incorporated herein by reference.
TECHNICAL FIELD
The present invention relates to a breast cancer therapeutic agent containing
Methods and compositions in breast cancer diagnosis and therapeutics
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
This invention was developed with funds from the United States Government. The United States Government has certain rights in the invention.
FIELD OF THE INVENTION
The present invention is directed to the fields of cancer and molecular genetics. Specifically, the present invention is directed to the
Methods and compositions in breast cancer diagnosis and therapeutics
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The present invention is directed to the fields of cancer and molecular genetics. Specifically, the present invention is directed to the determination of susceptibility to breast cancer and the diagnosis of invasive breast cancer. More specifically, the present invention is
Methods and compositions in breast cancer diagnosis and therapeutics
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The present invention is directed to the fields of cancer and molecular genetics. Specifically, the present invention is directed to the determination of susceptibility to breast cancer and the diagnosis of invasive breast cancer. More specifically, the present invention is
Id-1 gene and gene products as therapeutic targets for treatment of breast cancer and other types of carcinoma
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
REFERENCE TO ATTACHED SEQUENCE LISTING
This application incorporates by reference the attached sequence listing found in paper and electronic form.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention concerns a diagnosis, prognosis and treatment of breast, endometrium,
2-heterosubstituted 3-aryl-4H-1-benzopyran-4-ones as novel therapeutics in breast cancer
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims priority to copending U.S. patent application Ser. No. 10/634,463, filed Aug. 4, 2003, which claims priority to U.S. Provisional Patent Application No. 60/400,742, filed Aug. 2, 2002, the entirety of which is incorporated herein by
2-Heterosubstituted 3-aryl-4H-1-benzopyran-4-ones as novel therapeutics in breast cancer
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The present invention relates to compounds, particularly 2-heterosubstituted 3-aryl-4H-benzopyran-4-ones, for treating or preventing cancer in a mammalian subject and methods of making and using such 2-heterosubstituted 3-aryl-4H-benzopyran-4-ones.
BACKGROUND OF THE
Method of using estrogen-related receptor alpha (ERR.alpha.) status to determine prognosis, treatment strategy and predisposition to breast cancer, and method of using ERR.alpha. as a therapeutic target for the treatment of breast cancer
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION
The steroid/thyroid hormone nuclear receptor superfamily consists of a large number of transcription factors that regulate a wide variety of cellular processes (reviewed in Mangelsdorf, D. J., et al., Cell 83:835-839, 1995). The most highly conserved region of these
Use of imatinib (glivec,sti-571) to inhibit breast cancer resistance protein (BCRP)-mediated resistance to therapeutic agents
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
SUMMARY
This invention relates to a method of utilizing imatinib to inhibit BCRP and BCRP-mediated resistance to therapeutic agents in the treatment of cancer. The invention further relates to a method of treating cancers that demonstrate BCRP-mediated resistance to one or more therapeutic agents
Method for predicting response to breast cancer therapeutic agents and method of treatment of breast cancer
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
SEQUENCE LISTING
The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Dec. 4, 2015, is named 212181_0001_00_WO_SeqListing_ST25 and is 262,467 bytes in size.
FIELD
Diagnostic and therapeutic methods and compositions involving PTEN and breast cancer
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
SEQUENCE LISTING
A formal Sequence Listing has been submitted electronically with this application. This Sequence Listing is identical to the sequence listing in computer readable form submitted in the related U.S. Utility Application Ser. No. 10/983,011, filed Nov. 5, 2004. Its contents are
Diagnostic and therapeutic methods and compositions involving PTEN and breast cancer
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION
I. Field of the Invention
The present invention relates generally to the fields of molecular biology and oncology. More particularly, it concerns diagnostic, prognostic, and therapeutic methods and compositions involving ErbB2-overexpressing cancers and potential efficacy
Database tanaman obat terlengkap yang didukung oleh sains
- Bekerja dalam 55 bahasa
- Pengobatan herbal didukung oleh sains
- Pengenalan herbal melalui gambar
- Peta GPS interaktif - beri tag herba di lokasi (segera hadir)
- Baca publikasi ilmiah yang terkait dengan pencarian Anda
- Cari tanaman obat berdasarkan efeknya
- Atur minat Anda dan ikuti perkembangan berita, uji klinis, dan paten
Ketikkan gejala atau penyakit dan baca tentang jamu yang mungkin membantu, ketik jamu dan lihat penyakit dan gejala yang digunakan untuk melawannya.
* Semua informasi didasarkan pada penelitian ilmiah yang dipublikasikan
